Erik Zeger MD in Langhorne, Pennsylvania

Home Pennsylvania Langhorne

Erik Zeger MD has Medical Oncology as his primary medical specialty. Their primary office is: 1203 Langhorne Newtown Rd in Langhorne, Pennsylvania. There is an additional office location, for a total of two, for Erik Zeger MD that can be viewed further down.

They're a part of the: Alliance Cancer Specialists medical group which has around 54 members. You can call their office at 215-750-5050 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Hahnemann University College Of Medicine and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Erik Leroy Zeger MD Office Phone and Directions

Erik Zeger MD
Alliance Cancer Specialists
1203 Langhorne Newtown Rd
Langhorne, Pennsylvania 19047
215-750-5050

Patient Ratings
Please rate your experience with Erik Zeger MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 215-750-5050

Enter a starting address:

Healthcare Info for Erik Zeger MD

Medical School: Hahnemann University College Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Erik Zeger MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 2860432895
NPI #: 1639188659
NPI Created On: 08/07/2006
NPI Last Updated Listed as: 09/03/2019
Primary Taxonomy Code: 207RH0003X
License Number:
MD425881
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
AmeriHealth HMO, Inc.
Highmark Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Physician telephone patient service, 11-20 minutes of medical discussion
Injection, leucovorin calcium, per 50 mg
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, ferric carboxymaltose, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016493

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $96

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819137623

Being Disputed:: No

Product Related: Yes

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801690241

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153423

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $25

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783438015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835910445

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0579-28

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 841907689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology/Endocrinology

Name of Drug #1: SOMATULINE DEPOT

Open Associated Drug #1: 15054-0060-1

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ONIVYDE

Associated Drug #2: 15054-0043-1

Payments Total: $74

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834087959

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NERLYNX

Open Associated Drug #1: 70437-240-18

Additional Office Locations

1. Alliance Cancer Specialists
100 E Lancaster Ave
Wynnewood, PA 19096
Suite B20
Group Members: 54

Phone: 215-750-5050

Enter a starting address:

Medical Oncology Professionals in Langhorne

1.
Anjana Ranganathan

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

2.
Robert Reilly

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

Providers in Alliance Cancer Specialists

1.Bineetha Abraham

1000 Floral Vale Blvd
Yardley Pa 19067-5583
Alliance Cancer Specialists
Nurse Practitioner

2.Bineetha Abraham

2630 Holme Ave
Philadelphia Pa 19152-3004
Alliance Cancer Specialists
Nurse Practitioner

3.Sramila Aithal

1311 Bristol Pike
Bensalem Pa 19020-6415
Alliance Cancer Specialists
Hematology/oncology

4.Mitchell Alden

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

5.Zonera Ali Md

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

6.Zonera Ali Md

100 E Lancaster Ave
Wynnewood Pa 19096-3450
Alliance Cancer Specialists
Hematology/oncology

View all 54 members of Alliance Cancer Specialists medical group